Market News How it works Learn FAQ
| RCT 0.084 10.38% | NU 12.59 -16.95% | EWZ 34.15 -19.82% | BBD 2.93 -28.01% | TGL 0.2377 7.31% | AZTR 1.51 111.19% | ITUB 7.7 -20.37% | XP 15.705 -48.36% | NVD 3.99 -4.77% | SRTM 0.3 -30.28% | WFF 0.0898 12.25% | SPCX 146.9 -0.40% | PBR 22.5 -13.99% | SOXL 90.5 8.31% | INTC 90.47 4.04% | SHFS 0.094 -29.00% | VALE 12 -3.23% | NVDA 216.019 2.40% | CLRO 4.97 52.92% | NOK 8.64 6.14% | TSLL 10.76 10.25% | JBLU 2.37 -9.71% | CRWV 55.19 1.76% | GCDT 0.1497 -14.99% | SOXS 47.98 -8.54% | ABEV 2.83 -14.24% | NWGL 0.0857 4.51% | RWM 14.5 -0.34% | BITO 10.65 -1.66% | AAL 12.2 0.74% | RIG 6.53 1.87% | GPUS 0.1785 5.68% | TSLG 5.38 10.47% | T 20.85 -0.38% | SGRY 23.25 47.62% | IREN 25.43 2.11% | INTR 4.68 -34.91% | SBS 4.73 -26.09% | NFLX 63.9 -2.96% | GRAB 2.71 -2.87% | TSLA 391.62 5.21% | QID 14.22 -2.27% | WULF 11.98 5.83% | TQQQ 68.43 3.23% | CIFR 7.71 -2.90% | SID 0.9118 -22.73% | RBNE 0.1671 -12.05% | SPDN 8.5 -0.47% | VZ 43.1 -3.49% | PLUG 1.37 -0.72%
BSBioStem Technologies, Inc. logo

BioStem Technologies, Inc. (BSEM)

NASDAQ Capital Market · Currency in USD
$1.54 ▼ -0.03 (-1.91%)
At close: Oct 26, 4:00 PM ET. Market closed.
$1.52 ▼ -0.02 (-1.30%)
After hours: Oct 26, 4:43 PM ET

Summary

Previous Close
$1.57
Open
$1.57
Day's Range
$1.41 – $1.61
52 Week Range
$1.41 – $8.40
Volume
168,106
Avg. Volume
109,817
Market Cap
$28.76M
Beta (5Y Monthly)
0.27
PE Ratio (TTM)
--
EPS (TTM)
-$1.63
Earnings Date
Nov 12, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$7.00

Profile: BioStem Technologies, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
73
CEO
Jason Matuszewski

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014.

Earnings

Next report: Thu, Nov 12, 2026
EPS estimate -$0.43 · Revenue est. $7.17M
DateEst.Actual
Aug 12, 2026-$0.50-$0.52Miss
May 14, 2026-$0.28-$0.52Miss
Mar 24, 2026$0.02-$0.67Miss
Nov 13, 2025$0.02$0.03Beat
Aug 14, 2025$0.32-$0.03Miss
May 12, 2025$1.25$0.17Miss

Analyst view

Consensus price target
$7.00 ▲ +354.5%
Range $7.00 – $7.00

Similar stocks

Get free alerts on BSEM and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.